{
  "id": 7374315,
  "title": "FDA looks into reassessing criteria around rare disease trials, endpoint selection",
  "url": "https://urgent.news/2026/09/14/fda-looks-into-reassessing-criteria-around-rare-disease-trials",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-14T18:05:37.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-looks-into-reassessing-criteria-around-rare-disease-trials-endpoint-selection/"
  },
  "original_language": "en",
  "account": null,
  "summary": "As more rare disease treatments make their way to the FDA, the agency on Monday called for further outside input as it grapples with how much efficacy and safety data are sufficient to inform an ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}